...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Need An Explanation


Q: "I infer from what has happened that brokers to whom the company spoke probably said sure we can do an IPO but we believe the price should be 10 cents or so...."

SF: "....If you are correct, then that information would be an abomonation: All these years of developing this IP and the true market value would be 10 lousy cents?
That's insane. What a waste of time Zenith is if the shares are worth 10 cents...."

C'mon. Of course 10¢ is not correct. What if he had said 1.5¢ ?

If somebody makes something up, let's not run with it as though it has any semblance to reality.

Share
New Message
Please login to post a reply